Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Grant or award Chief Accounting Officer acquired 3,433 shares (grant or award)
  2. 4 Planned sale CFO and Treasurer sold 10,000 shares at $100.52 ($1,005,200)
  3. 4 Open-market sale Director sold 3 shares at an average $93.84 ($282)
  4. 4 Grant or award Chief Commercial Officer acquired 14,928 shares (grant or award)
  5. 4 Grant or award See Remarks acquired 23,884 shares (grant or award)
  6. 4 Grant or award CFO and Treasurer acquired 23,884 shares (grant or award)
  7. 4 Planned sale President sold 2,084 shares at $98.00 ($204,232)
  8. 4 Grant or award CEO acquired 70,909 shares (grant or award)
  9. 4 Shares withheld for taxes See Remarks gave up 12,907 shares (to pay taxes)
  10. 4 Shares withheld for taxes CFO and Treasurer gave up 20,261 shares (to pay taxes)
  11. 4 Shares withheld for taxes CEO gave up 8,637 shares (to pay taxes)
  12. 4 Shares withheld for taxes President gave up 16,594 shares (to pay taxes)
  13. 4 Planned sale Director sold 53,107 shares at an average $94.35 ($5,010,734)
  14. 4 Shares withheld for taxes Chief Commercial Officer gave up 759 shares (to pay taxes)
  15. 4/A Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 563 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale Director sold 1,000 shares at $94.76 ($94,760)
  19. 4 Shares withheld for taxes CEO gave up 15,446 shares (to pay taxes)
  20. 4 Planned sale CFO and Treasurer sold 10,000 shares at $81.20 ($812,000)

Page 4 of 30 · 598 filings